7.16
-0.17
(-2.32%)
At close: January 10 at 7:31:07 PM GMT+1
Loading Chart for R9U2.BE
DELL
- Previous Close
7.34 - Open
7.32 - Bid 6.97 x --
- Ask 7.37 x --
- Day's Range
7.16 - 7.36 - 52 Week Range
7.16 - 14.25 - Volume
0 - Avg. Volume
1 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: R9U2.BE
View MorePerformance Overview: R9U2.BE
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
R9U2.BE
2.18%
S&P/TSX Composite index
0.60%
1-Year Return
R9U2.BE
31.04%
S&P/TSX Composite index
18.10%
3-Year Return
R9U2.BE
60.93%
S&P/TSX Composite index
17.47%
5-Year Return
R9U2.BE
16.20%
S&P/TSX Composite index
43.70%
Compare To: R9U2.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
7.17
-2.32%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.8250
-1.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1858
+13.29%
Mkt Cap EUR 32.885M
Industry Drug Manufacturers—Specialty & Generic
5.15
-1.90%
Mkt Cap EUR 426.451M
Industry Drug Manufacturers—Specialty & Generic
0.3220
-3.01%
Mkt Cap EUR 112.486M
Industry Drug Manufacturers—Specialty & Generic
1.1400
-2.56%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.55
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.35
-0.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.15
-2.83%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.7420
-0.84%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: R9U2.BE
View MoreValuation Measures
As of 1/9/2025
Market Cap
1.72B
Enterprise Value
2.07B
Trailing P/E
28.02
Forward P/E
13.95
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.62
Price/Book (mrq)
1.01
Enterprise Value/Revenue
1.90
Enterprise Value/EBITDA
5.66
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--